Sunday, February 28, 2021
  • Contact
  • Privacy Policy
  • Terms & Conditions
Trends Wide
  • Home
  • News
  • Business
  • Lifestyle
  • Trending
  • Australia
  • Deals
  • Cryptocurrency
No Result
View All Result
Trends Wide
Home Economie

Gilead Sciences shares rise as Morgan Stanley upgrades its price target to $83

souhaib by souhaib
January 22, 2021
in Economie
0


Gilead Sciences (NASDAQ: GILD) shares are advancing this January, and at the current stock price, this company is fairly valued, in my opinion. The company is moving in the right direction, and the positive news is that Morgan & Stanley upgraded its price target on Gilead Sciences.

Fundamental analysis: Gilead Sciences continues to expand its business

Gilead Sciences is an American biopharmaceutical company that focuses on researching and developing antiviral drugs used to treat HIV, hepatitis B, hepatitis C, and influenza.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

The company reported Q3 results in the last week of October; total revenue has increased by 17.1% Y/Y to $6.56B while Q3 GAAP EPS was $0.29 (misses by $0.96). Total revenue has risen above the expectations (+$260M), and the company has declared a $0.68/quarterly share dividend.

Gilead Sciences shares have advanced more than 14% in the 2021 year, and the current price stands around $67. Morgan Stanley raised its price target to $83 for GILD, and Gilead Sciences remains one of its top biopharmaceuticals picks for 2021.

Gilead Sciences has revised the FY2020 earnings outlook in the second week of January, and the company expects product sales to be around $24.3B vs. the prior outlook of $23B. Operating income should be about $11.65B while adjusted EPS is expected to be around $7 vs. previous guidance of $6.25-$6.60.

Gilead Sciences also expects growth in 2021 with higher than expected sales of Veklury (remdesivir). The company expects higher sales of its oncology assets together with contributions from HIV therapies based on lenacapavir.

Gilead Sciences continues to expand its business, and the company has agreed to buy MYR GmbH (German maker of hepatitis drug) in a $1.4B deal. The company also acquired Immunomedics (NASDAQ: IMMU) this September in a deal worth around $21B.

Positive information is that CEO Daniel O’Day said last week that Gilead Sciences is testing remdesivir to determine whether it effectively treats new coronavirus strains.

“Remdesivir works at the source in the cell where the virus replicates, and what we know is in these new variants, that part of the cell is not changing at all in fact. So, we fully expect remdesivir to be effective against these new strains,” said Daniel O’Day, CEO of Gilead Sciences.

Technical analysis: Gilead Sciences shares are advancing, and $70 represents the first resistance

Gilead Sciences shares are advancing at the beginning of this year, and with $83.9B market capitalization, this company is reasonably valued.

Data source: tradingview.com

The critical support levels are $60 and $55; $70, $75, and $80 represent the resistance levels. If the price jumps above $70, it would be a signal to trade shares, and the next target could be around $75, but if the price falls below the $60 support level, it would be a firm “sell” signal.

Summary

Gilead Sciences shares are advancing this January, and at the current stock price, this company is fairly valued, in my opinion. CEO Daniel O’Day said last week that Gilead Sciences fully expects its remdesivir to be effective against coronavirus’s new strains. Gilead Sciences expects growth in 2021, while Morgan Stanley raised its price target to $83 for GILD.



Source link

Related posts

Rightmove’s revenue slides 29% in 2020 despite record number of visitors.

February 26, 2021

Salesforce says its full-year revenue topped £14 billion for the first time.

February 26, 2021
Next Post

Yemen .. Renewed clashes between government forces and the Houthis in Hodeidah

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Disney World, Disneyland to update Jungle Cruise's depictions of Indigenous people

1 month ago

As ice from winter storm thaws, southern pool owners wait to learn extent of damage

1 week ago

Hot Pockets recall: Nestle recalls nearly 763K pounds due to possible glass, plastic contamination

1 month ago

Mural of Winston Churchill attracts complaints from woke brigade

3 months ago

BROWSE BY CATEGORIES

  • Australia
  • Cryptocurrency
  • Culture
  • Deals
  • Discounts
  • Economie
  • Euro
  • Gaming
  • Lifestyle
  • News
  • Opinion
  • Sports
  • Switzerland
  • Trending
  • Uncategorized

BROWSE BY TOPICS

2018 League abc Australia Bali United bbc bbc health Budget Travel Champions League Chopper Bike cnn ar business dailymail dailymail australia dailymail heath dailymail money dailymail sport day 7 euronews Health https://lenews.ch/feed/ IGN Istana Negara Market Stories National Exam rt arabic usa today usa today money usa today sport Visit Bali Women Fashion

POPULAR NEWS

  • Watch .. Lebanese astronomer Michel Hayek reveals his predictions for the year 2021

    0 shares
    Share 0 Tweet 0
  • Help save a local business

    0 shares
    Share 0 Tweet 0
  • Love Insurance

    0 shares
    Share 0 Tweet 0
  • 5 places to visit in Microsoft Flight Simulator 2020.

    0 shares
    Share 0 Tweet 0
  • Reece Parkinson: A shock diagnosis won’t stop me running

    0 shares
    Share 0 Tweet 0

Follow us on social media:

Recent News

  • Mother’s nightmare as ‘loving’ husband turned out to be conman with another wife and FIVE fiancee’s
  • “Persona non grata” … the EU ambassador leaves Venezuela on Tuesday
  • Lara Bingle has a Baywatch moment on the beach as she stuns in a bright red costume

Category

  • Australia
  • Cryptocurrency
  • Culture
  • Deals
  • Discounts
  • Economie
  • Euro
  • Gaming
  • Lifestyle
  • News
  • Opinion
  • Sports
  • Switzerland
  • Trending
  • Uncategorized

Recent News

Mother’s nightmare as ‘loving’ husband turned out to be conman with another wife and FIVE fiancee’s

February 28, 2021

“Persona non grata” … the EU ambassador leaves Venezuela on Tuesday

February 28, 2021
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • News
  • Business
  • Culture
  • National
  • Sports
  • Lifestyle
  • Opinion

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.